EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-17.08%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$1.72B
AUM Growth
-$541M
(-24%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
20.3%
Holding
982
New
34
Increased
134
Reduced
120
Closed
36
Top Buys
| 1 |
Marriott International Class A Common Stock
MAR
|
$13.5M |
| 2 |
IQVIA
IQV
|
$13M |
| 3 |
Darden Restaurants
DRI
|
$12M |
| 4 |
Gilead Sciences
GILD
|
$7.13M |
| 5 |
Coterra Energy
CTRA
|
$6.7M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
$29.9M |
| 2 |
Biogen
BIIB
|
$28.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.2M |
| 4 |
CVS Health
CVS
|
$23.2M |
| 5 |
AMRN
Amarin Corp
AMRN
|
$20.9M |
Sector Composition
| 1 | Healthcare | 27.96% |
| 2 | Technology | 23.65% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Financials | 9.02% |
| 5 | Communication Services | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Avery Dennison
AVY
$13.1B
| $682K | 0.04% |
6,510
+1,640
| +34% | +$172K |
|
|
EIDX
277
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $665K | 0.04% |
13,600
| – | – |
|
278
Axsome Therapeutics
AXSM
$6.25B
| $662K | 0.04% |
+11,500
| New | +$662K |
|
279
McDonald's
MCD
$224B
| $653K | 0.04% |
3,900
| – | – |
|
280
Banco Bradesco
BBD
$33.6B
| $646K | 0.04% |
208,254
| – | – |
|
281
Etsy
ETSY
$5.36B
| $644K | 0.04% |
16,656
+973
| +6% | +$37.6K |
|
282
TC Energy
TRP
$53.9B
| $638K | 0.04% |
15,600
+400
| +3% | +$16.4K |
|
283
Prologis
PLD
$105B
| $637K | 0.04% |
7,726
-26
| -0.3% | -$2.14K |
|
284
Verisk Analytics
VRSK
$37.8B
| $625K | 0.04% |
4,530
| – | – |
|
285
Canadian Solar
CSIQ
$748M
| $608K | 0.04% |
38,900
| – | – |
|
286
Cigna
CI
$81.5B
| $606K | 0.04% |
3,400
| – | – |
|
287
Enbridge
ENB
$105B
| $583K | 0.03% |
20,800
-16,200
| -44% | -$454K |
|
288
Morgan Stanley
MS
$236B
| $578K | 0.03% |
+16,600
| New | +$578K |
|
289
Alaska Air
ALK
$7.28B
| $575K | 0.03% |
20,300
-2,100
| -9% | -$59.5K |
|
290
Take-Two Interactive
TTWO
$44.2B
| $564K | 0.03% |
4,969
+447
| +10% | +$50.7K |
|
|
SAGE
291
DELISTED
Sage Therapeutics
SAGE
| $552K | 0.03% |
18,700
| – | – |
|
|
PETQ
292
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $550K | 0.03% |
25,619
+18,549
| +262% | +$398K |
|
293
Lincoln National
LNC
$7.98B
| $546K | 0.03% |
20,000
| – | – |
|
294
Fidelity National Financial
FNF
$16.5B
| $528K | 0.03% |
20,800
| – | – |
|
295
Celanese
CE
$5.34B
| $518K | 0.03% |
+6,990
| New | +$518K |
|
296
American International
AIG
$43.9B
| $514K | 0.03% |
20,000
-5,000
| -20% | -$129K |
|
297
Ligand Pharmaceuticals
LGND
$3.25B
| $513K | 0.03% |
11,542
| – | – |
|
298
Travere Therapeutics
TVTX
$1.93B
| $507K | 0.03% |
35,600
| – | – |
|
299
Danaher
DHR
$143B
| $493K | 0.03% |
+3,948
| New | +$493K |
|
300
W.R. Berkley
WRB
$27.3B
| $491K | 0.03% |
20,250
| – | – |
|